Neumora Therapeutics, Inc.
NMRA
$1.28
-$0.12-8.57%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -32.25% | -33.02% | 14.63% | 22.33% | 22.08% |
Total Receivables | -- | -- | 174.58% | 15.12% | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -70.75% | 292.27% | 232.70% | 260.55% | 1,012.30% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -80.75% | -91.30% | 98.90% | 18.14% | -53.45% |
Total Current Assets | -34.34% | -33.69% | 18.33% | 23.01% | 23.28% |
|
|||||
Total Current Assets | -34.34% | -33.69% | 18.33% | 23.01% | 23.28% |
Net Property, Plant & Equipment | -57.47% | -50.19% | -43.10% | -39.11% | -35.56% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -74.55% | -70.71% | -70.60% |
Total Assets | -36.12% | -35.28% | 12.37% | 14.82% | 16.41% |
|
|||||
Total Accounts Payable | 881.31% | 173.98% | -86.76% | 31.45% | -95.28% |
Total Accrued Expenses | 15.69% | -2.52% | 26.80% | 14.33% | 84.27% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -45.15% | -19.22% | 8.55% | 4.33% | 0.24% |
Total Finance Division Other Current Liabilities | -4.32% | -10.74% | -15.82% | -46.15% | -91.55% |
Total Other Current Liabilities | -4.32% | -10.74% | -15.82% | -46.15% | -91.55% |
Total Current Liabilities | 19.02% | 9.00% | -11.36% | 13.00% | 5.97% |
|
|||||
Total Current Liabilities | 19.02% | 9.00% | -11.36% | 13.00% | 5.97% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -78.16% | -63.47% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -85.81% | -70.74% | -59.73% | -51.97% | -75.32% |
Total Liabilities | 10.28% | -0.80% | -22.12% | -2.50% | -7.75% |
|
|||||
Common Stock & APIC | 5.26% | 9.15% | 4,088.71% | 4,532.51% | 5,370.94% |
Retained Earnings | -34.66% | -49.39% | -50.62% | -50.49% | -50.46% |
Treasury Stock & Other | 181.58% | 133.76% | 58.26% | 50.34% | 90.18% |
Total Common Equity | -38.80% | -37.44% | 174.24% | 188.83% | 204.97% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -38.80% | -37.44% | 174.24% | 188.83% | 204.97% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -38.80% | -37.44% | 15.48% | 16.07% | 18.20% |
|